A prevalence study and description of alli® use by patients with eating disorders

Kristine J. Steffen, James E. Mitchell, Daniel Le Grange, Scott J. Crow, Evelyn Attia, Cynthia M. Bulik, Jocilyn E. Dellava, Ovidio Bermudez, Ann L. Erickson, Ross D. Crosby, Vidhu P. Bansal-Dev

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Objective: This study examined the frequency and characteristics of alli® use among patients in eating disorder treatment facilities. Method: Patients from five treatment centers completed the Survey of Eating and Related Behaviors. Diagnoses were determined from survey responses. Results: Of 417 survey respondents, 26 (6.2%) reported a history of alli® use. Of those, 15 (57.7%) met criteria for an eating disorder, including one of 29 patients (3.4%) with anorexia nervosa binge-purge subtype, six of 66 patients (9.1%) with full or subthreshold bulimia nervosa, four of 49 (8.2%) with binge eating disorder, one of six (16.7%) with purging disorder, and three of 80 (3.8%) with an eating disorder not otherwise specified. Discussion: The results of this survey suggest that patients with eating disorders use alli®, albeit relatively uncommonly. Therefore, it is worthwhile for clinicians to inquire about alli® use when evaluating or treating these patients in any clinical setting.

Original languageEnglish (US)
Pages (from-to)472-479
Number of pages8
JournalInternational Journal of Eating Disorders
Issue number5
StatePublished - Jul 2010


  • Alli
  • Anorexia nervosa
  • Binge eating disorder
  • Bulimia nervosa
  • Compensatory method
  • Diet pill
  • Eating disorders
  • Orlistat


Dive into the research topics of 'A prevalence study and description of alli® use by patients with eating disorders'. Together they form a unique fingerprint.

Cite this